Confidence intervals and point estimates for treatment effects in adaptive enrichment designs.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: metastatic colorectal cancer
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Moreover, the median-unbiased estimators and conditional moment estimators have good performance with respect to median and mean bias, respectively. The method is illustrated by a re-analysis of a trial investigating treatment interactions with KRAS mutation type in patients with metastatic colorectal cancer.
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.7%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
Adaptive enrichment designs allow subgroup selection of the patient population within a confirmatory trial via an interim analysis.
APA
Zhu J, Titman A, Wan F (2026). Confidence intervals and point estimates for treatment effects in adaptive enrichment designs.. Statistical methods in medical research, 9622802261423180. https://doi.org/10.1177/09622802261423180
MLA
Zhu J, et al.. "Confidence intervals and point estimates for treatment effects in adaptive enrichment designs.." Statistical methods in medical research, 2026, pp. 9622802261423180.
PMID
41731731 ↗
Abstract 한글 요약
Adaptive enrichment designs allow subgroup selection of the patient population within a confirmatory trial via an interim analysis. However, this design complicates treatment effect estimation and uncertainty quantification. This paper introduces a -value inversion method using various sample space orderings to construct confidence intervals either unconditionally or conditional on the subgroup selected for a general class of two-stage two-group designs. In addition, the -value functions can be used to derive median-unbiased estimators and conditional moment estimators. Through simulation it is shown that the proposed intervals have close to nominal coverage, in contrast to naive confidence intervals based on the maximum likelihood estimator. Moreover, the median-unbiased estimators and conditional moment estimators have good performance with respect to median and mean bias, respectively. The method is illustrated by a re-analysis of a trial investigating treatment interactions with KRAS mutation type in patients with metastatic colorectal cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Pooled safety analysis of zanubrutinib monotherapy in Asian patients with B-cell malignancies.
- Comparison of postoperative reflux esophagitis in different digestive tract reconstruction methods after proximal gastrectomy for proximal gastric cancer patients: a network meta-analysis and systematic review.
- LRRC15 in tumorigenesis, progression, and therapy.
- Efficacy and cost-effectiveness of extending risk-stratified colorectal cancer screening: evidence from China's first province-wide program.
- VAMP7 governs ferroptosis suppression and cisplatin resistance in esophageal cancer: a dual-targeting therapeutic paradigm.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- The Barriers and Enablers to Participation in Oncology Clinical Trials for Ethnically Diverse Communities: A Qualitative Systematic Review Using Metaethnography.
- Updates on Clinical Trials and Molecular Characteristics of Locally Advanced and Oligometastatic Renal Cell Carcinoma.
- Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE).
- Quality of Life Measurement in PARP Inhibitor Trials of Epithelial Ovarian Cancer - What Do We Know?
- Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095.
- Statistical operating characteristics of current early phase dose finding designs with toxicity and efficacy in oncology.